Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024)
Cytek Biosciences (CTKB) posted Short-term Investments of $29000.0 for Q4 2024, down 6.45% on a QoQ basis from $31000.0 in Q3 2024, and down 91.24% year-over-year from $331000.0 in Q1 2024.
Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024) Analysis & Trends
Cytek Biosciences' Short-term Investments history runs 4 years deep, the most recent figure standing at $29000.0 for Q4 2024.
- Quarterly Short-term Investments fell 91.24% year-over-year to $29000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $29000.0 (down 91.24% YoY) and the FY2024 annual result came in at $29000.0, down 91.24% from the prior year.
- Short-term Investments was $29000.0 for Q4 2024 at Cytek Biosciences, down from $31000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $2.9 million in Q1 2023 and bottomed at $29000.0 in Q4 2024.
- A 4-year average of $940750.0 and a median of $365500.0 in 2023 frame the typical range for Short-term Investments.
- Peak annual rise in Short-term Investments reached 86.29% in 2024, while the deepest fall reached 91.24% in 2024.
- Cytek Biosciences' Short-term Investments stood at $888000.0 in 2020, then jumped by 226.46% to $2.9 million in 2022, then sank by 88.58% to $331000.0 in 2023, then sank by 91.24% to $29000.0 in 2024.
- Business Quant data shows CTKB's Short-term Investments at $29000.0 in Q4 2024, $31000.0 in Q3 2024, and $30000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 331,000.00 |
| Mar 31, 2023 | 2.92 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Dec 31, 2020 | 888,000.00 |